drugset / Trial / NCT01362010

Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients

NCT01362010

Phase 2 Completed 150 enrolled Vyne Therapeutics Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the tolerability and safety and to determine whether FXFM244 Antibiotic Foam is effective in the treatment of Acne Vulgaris.

Timeline

Start
2012-01
Primary completion
2013-06
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 1 % Topical
Subject Minocycline Small molecule 4 % Topical

Indications